Ionis Pharmaceuticals IONS Accrued interest
Accrued interest at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestPayableCurrentAndNoncurrent.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's accrued interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's accrued interest?
- Ionis Pharmaceuticals (IONS) reported accrued interest of $26.04M in Q4 2025.
- What does accrued interest mean?
- Interest costs that have been incurred but not yet paid.
- How do you interpret accrued interest?
- A rising balance may indicate increasing debt levels or a shift in payment schedules, potentially impacting short-term cash flow.
- How does accrued interest compare across companies?
- Standard accounting accrual found in most companies with interest-bearing debt.